Get ready to discover the eagerly anticipated third quarter financial results of Amgen (NASDAQ: AMGN) on Wednesday 30th October 2024. This significant announcement is scheduled to take place after market close, giving investors and analysts a chance to gain valuable insights into the company's financial performance.
Wall Street financial experts forecast that the concern is set to announce an expected $5.11 profit per share for the quarter. Moreover, the company is anticipated to disclose a total revenue of $8.52 billion for this particular period.
Wall Street analysts have provided their insights on the company's performance for the year, forecasting a total revenue of $33.21 billion. Additionally, they anticipate the earnings per share to reach profit of $19.49 during the fiscal year.
The per-share income of $4.96 was highlighted in the company's earnings report for the same quarter of the prior year. This notable figure was achieved due to the company's impressive total revenue of $6.9 billion recorded during that specific period.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $4.97 | -0.6% | 8.39 B | +20.1% |
| Q1 2024 | $3.96 | -0.5% | 7.45 B | +22.0% |
| Q4 2023 | $4.71 | +15.2% | 8.20 B | +19.8% |
| Q3 2023 | $4.96 | +5.5% | 6.90 B | +3.8% |
| Q2 2023 | $5.00 | +7.5% | 6.99 B | +5.9% |
| *Growth on year-over-year basis | ||||
AMGN will host a conference call with investment community on 30th October 2024 at 04:30 PM eastern time to discuss the financial results.
Amgen (AMGN) shares traded as low as $315.90 and as high as $320.14 on a day volume of 1.82 million shares, closed Monday's regular trading session at $317.17, a gain of 0.06 percent.
